Treatments

Bone Marrow Transplant

Bone Marrow Transplant

Bone Marrow Transplant (BMT), also known as Hematopoietic Stem Cell Transplantation, is a life-saving medical procedure used to treat various diseases, including cancers like leukemia, lymphoma, and multiple myeloma, as well as non-malignant conditions such as aplastic anaemia, sickle cell anaemia, thalassemia,  and immune deficiency disorders.

Understanding the BMT Process 

The BMT process begins with the selection of a suitable donor. The donor could be the patient himself (autologous transplant) or another person (allogeneic transplant) whose bone marrow matches the patient's. The matching is determined through specialized blood tests called HLA typing.

Pre-transplant: The patient undergoes conditioning, which involves chemotherapy, with or without radiation, to destroy any diseased cells and make room for the new stem cells. The intensity of conditioning can vary, leading to different transplant experiences.

Following conditioning, the transplant itself involves infusing the donor's stem cells into the patient's bloodstream, a process that is similar to a blood transfusion. These stem cells then migrate to the bone marrow and begin the process of generating healthy blood cells, a phase known as engraftment.

Types of Bone Marrow Transplants

Autologous Transplant: Utilizes the patient's own stem cells, collected in advance and stored for future transplantation. This method is often preferred for treating certain types of cancer, as it carries a lower risk of infection and immune reactions.

Allogeneic Transplant: Involves stem cells sourced from a donor. The donor could be a family member, a genetically matched unrelated donor, or cord blood from a new-born. This type is commonly used for conditions that have damaged the patient's own marrow.

Haploidentical Transplant: A form of allogeneic transplant where the donor is a half-match, usually a family member. Advances in transplant technology have made haploidentical transplants more successful in recent years.

Precautions and Preparation

Prior to BMT, patients undergo thorough evaluations, including physical exams, blood tests, and imaging studies, to assess their overall health and suitability for the procedure. Pre-transplant vaccinations are also common to reduce the risk of infections post-transplant.

Patients and caregivers should prepare for a lengthy hospital stay and post-transplant recovery period. This includes making arrangements for home care, financial planning, and understanding the risk of complications such as graft-versus-host disease (GVHD) in allogeneic transplants.

Recovery and Aftercare

The recovery period post-BMT can vary, depending on the type of transplant, the patient's condition before the transplant, and any complications that may arise. Initially, patients are closely monitored for infections, GVHD, and engraftment syndrome.

Patients may experience fatigue, weakness, and other side effects from the conditioning treatment, and it can take a couple of months to a year for the immune system to fully recover. During this time, it's crucial to follow strict infection prevention guidelines, maintain a healthy diet, and attend regular follow-up appointments with the healthcare team.

Long-term aftercare focuses on monitoring for late effects of the transplant, such as secondary cancers, organ dysfunction, and continued immune system recovery. Psychological support and rehabilitation services may also be necessary to help patients and their families adjust to life post-transplant.

Bone Marrow Transplant is a complex but potentially curative treatment for several serious diseases. With careful preparation, strict adherence to post-transplant care guidelines, and ongoing medical and psychological support, in most cases, outcomes are promising.

What Our Doctors Say

Discover inspiring stories of healing and hope. Our doctors share their journeys, insights, and commitment to patient care.

What is Gene Therapy- Dr Gaurav Kharya

Dr Gaurav Kharya

Director, Department of BMT and Cellular Therapy

Haploidentical Transplants Have a 90% Success Rate | Dr. Gaurav Kharya Explains

Dr Gaurav Kharya

Director, Department of BMT and Cellular Therapy

Successful Bone Marrow Transplant of Akshat Sahu

Dr Gaurav Kharya

Director, Department of BMT and Cellular Therapy

Bone Marrow Transplant | Happy Patient Successful Story | Dr. Gaurav Kharya | Apollo Hospital

Dr Gaurav Kharya

Director, Department of BMT and Cellular Therapy

From Pain to Hope: Deborah’s Journey to Beating Sickle Cell Disease At Apollo Hospital Delhi

Dr Gaurav Kharya

Director, Department of BMT and Cellular Therapy

We are dedicated to your child's well-being, offering top-tier medical care with expertise, empathy, and a focus on healing. Our specialties include pediatric oncology, hematology, immunology, and bone marrow transplant.

Our Location

Indraprastha Apollo Hospital, New Delhi -110076

Useful Links

    Working Hours

      © 2024 Designed and Developed by Medipage Communications. All Rights Reserved